Navigation Links
Cyberonics Announces Conference Call to Discuss Fiscal Year 2009 Third Quarter Financial Results
Date:2/4/2009

HOUSTON, Feb. 4 /PRNewswire-FirstCall/ -- Cyberonics, Inc. (Nasdaq: CYBX) today announced that the company will report financial results for the third quarter ended January 23, 2009 of its fiscal year ending April 24, 2009 on Wednesday, February 18, 2009 at 5:00 PM EST. The company will conduct a conference call to discuss those results on Thursday, February 19, 2009 at 9:00 AM EST.

Fiscal Year 2009 Third Quarter Results Conference Call Instructions

To listen to the conference call live by telephone dial 877-313-8035 (if dialing from within the U.S.) or 706-679-4838 (if dialing from outside the U.S.). The conference ID is 83141875. Presentation slides will be available on-line at www.cyberonics.com no later than 8:00 AM EST on Thursday, February 19, 2009. A replay of the conference call will be available approximately two hours after the completion of the live call by dialing 800-642-1687 (if dialing from within the U.S.) or 706-645-9291 (if dialing outside the U.S.). The replay conference ID access code is 83141875. The replay will be available for one week on the above number, and subsequently on the company's website for a period of six months.

About Cyberonics, Inc. and VNS Therapy(TM)

Cyberonics, Inc. (NASDAQ: CYBX) is a medical technology company with core expertise in neuromodulation. The company developed and markets the Vagus Nerve Stimulation (VNS) Therapy(TM) System, which is FDA-approved for the treatments of epilepsy and depression. The VNS Therapy System uses a surgically implanted medical device that delivers electrical pulsed signals to the vagus nerve. Cyberonics markets the VNS Therapy System in selected markets wor
'/>"/>

SOURCE Cyberonics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Cyberonics Names Milton M. Morris, Ph.D. Vice President, Research & Development
2. Cyberonics to Present at Piper Jaffray 20th Annual Health Care Conference
3. Cyberonics Reports Strong Sales Growth and Profitability in Fiscal 2009 Second Quarter
4. Cyberonics Announces Conference Call to Discuss Fiscal Year 2009 Second Quarter Financial Results
5. Cyberonics Provides Business Update Based on Final Ambulatory Payment Classification Rate Change Announcement by CMS
6. Cyberonics Corporate Headquarters Fully Operational Following Hurricane Ike
7. Cyberonics to Present at UBS Global Life Sciences Conference
8. Cyberonics to Present at Canaccord Adams 28th Annual Global Growth Conference
9. Cyberonics Announces Conference Call to Discuss Fiscal Year 2009 First Quarter Financial Results
10. Cyberonics to Present at Collins Stewart Fourth Annual Growth Conference
11. Cyberonics Announces Conference Call to Discuss Fourth Quarter and Fiscal Year 2008 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... problems must be weighed first, study finds , , TUESDAY, Dec. ... the end-all factor for people with type 2 diabetes who ... degree of blood sugar control in type 2 diabetes "has ... Sheldon Greenfield, a professor of medicine at the University of ... the Dec. 15 issue of the Annals of Internal ...
(Date:12/15/2009)... At a time when Americans spend over $50 billion ... Raymond Hall is theorizing a painful connection between conventional ... called Pillo1 ( www.pillo1.com ) to address the problem. ... John,s Medical Plaza Sleep Disorders Center showed that Pillo1 ... position and promotes increased time spent in REM (rapid ...
(Date:12/15/2009)... For. , ... Alpharetta, GA (Vocus) Dec. 14, 2009 ... temporary physician and CRNA staffing, as the #4 Best Staffing Firm ... ,“We are proud to be recognized on this list because it ... R. Shane Jackson president of LocumTenens.com. “Unquestionably, we know that our ...
(Date:12/15/2009)... will require that certain businesses with large areas where people ... readily available. Fire and rescue personnel agree that for any ... investment. , ... Issaquah, WA (PRWEB) ... require that certain businesses with large areas where people gather, ...
(Date:12/15/2009)... the Dec. 15 issue of the Journal ... associations exist between parent-reported insomnia symptoms and medical ... school-aged children. , Results of multivariate regression ... more likely in children with gastrointestinal regurgitation and ... Nineteen percent of children met the criteria ...
Breaking Medicine News(10 mins):Health News:Tighter Blood Sugar Control Not Best for Some Diabetics 2Health News:Tighter Blood Sugar Control Not Best for Some Diabetics 3Health News:Sleep Study Shows Pillo1 Re-Educates Body to Naturally Move Into Optimal Sleep Position and Increases REM Sleep by 21.3% 2Health News:LocumTenens.com Named 4th Best Staffing Firm to Work For 2Health News:QuickMedical Responds to Oregon Bill Requiring Businesses to Carry Defibrillators 2Health News:QuickMedical Responds to Oregon Bill Requiring Businesses to Carry Defibrillators 3Health News:Insomnia symptoms linked with medical complaints in young school-aged children 2Health News:Insomnia symptoms linked with medical complaints in young school-aged children 3
... "TOGETHER ... HIV STOPS WITH US",is the ... in areas across,the country including: Boston, Long Beach ... real HIV positive people, and a,wide spectrum of ... members,friends, care providers and partners talking about real ...
... often, it reduces bleeding problems, study finds , , MONDAY, Aug. ... from the wrist rather than the groin reduces the incidence ... The approach, using the radial artery in the wrist, is ... analysis of almost 600,000 catheterizations in a national database, said ...
... LOS ANGELES, Aug. 18 Today a representative ... Term Care Workers, Local,6434 ("ULTCW") filed a letter ... ("UHW-W")., In the letter written to President ... -- an elected Vice President of ULTCW and,member ...
... PALO ALTO, Calif., Aug. 18 Based on ... & Sullivan presents ConforMIS,with the 2008 North American ... This recognition is in support of the company,s,unique ... each,individual unlike traditional implants that require surgeons to ...
... In up to 20 percent of people infected with ... and cross into the brain, resulting in HIV-associated dementia ... Einstein College of Medicine of Yeshiva University have found ... of intestinal bacteriaa chemical present in high levels in ...
... Market Intelligence and Competitive Analysis from, Thomson Reuters ... LONDON and PHILADELPHIA, Aug. 18 Thomson ... businesses and,professionals, has announced the availability of the ... Launched more than two years,ago, the quarterly Pharma ...
Other Medicine News:Health News:New HIV Prevention/Anti-Stigma Campaign Featuring HIV Positive & Negative Persons 'TOGETHER' Launches Across the Nation 2Health News:Reaching the Heart Through the Wrist 2Health News:Reaching the Heart Through the Wrist 3Health News:Frost & Sullivan Honors ConforMIS for Its Contribution to Personalized Care Through its Customized Implant Development Technologies 2Health News:Frost & Sullivan Honors ConforMIS for Its Contribution to Personalized Care Through its Customized Implant Development Technologies 3Health News:Frost & Sullivan Honors ConforMIS for Its Contribution to Personalized Care Through its Customized Implant Development Technologies 4Health News:Chemical liberated by leaky gut may allow HIV to infect the brain, Einstein scientists find 2Health News:Chemical liberated by leaky gut may allow HIV to infect the brain, Einstein scientists find 3Health News:Chemical liberated by leaky gut may allow HIV to infect the brain, Einstein scientists find 4Health News:The Scientific Business of Thomson Reuters Publishes Three Pharma Matters Reports Covering the First Quarter of 2008 2Health News:The Scientific Business of Thomson Reuters Publishes Three Pharma Matters Reports Covering the First Quarter of 2008 3
(Date:12/15/2009)... Today, Hill-Rom Holdings, Inc. (NYSE: ... on significant strategic and financial initiatives at its ... Conference is hosted by Peter H. Soderberg, president ... on the following topics: ,, Status of ... development and financial updates Smart technologies that ...
(Date:12/15/2009)... Rib-X Pharmaceuticals, Inc., a company focused ... drugs for the treatment of serious multi-drug-resistant infections ... research agreement with Massachusetts General Hospital (MGH). ... collaboration, Dr. David Hooper of MGH will evaluate ... model to determine resistance development and to validate ...
(Date:12/15/2009)... SAN DIEGO, INDIANAPOLIS, and CAMBRIDGE, Mass., Dec. 15 ... AMLN ), Eli Lilly and Company (NYSE: ... ALKS ) today announced positive results from ... investigational diabetes therapy, to BYETTA® (exenatide) injection taken ... After 24 weeks of treatment, patients taking exenatide ...
Breaking Medicine Technology:Hill-Rom Investor Conference Features Business Strategy Updates and New Technologies 2Hill-Rom Investor Conference Features Business Strategy Updates and New Technologies 3Hill-Rom Investor Conference Features Business Strategy Updates and New Technologies 4Hill-Rom Investor Conference Features Business Strategy Updates and New Technologies 5Hill-Rom Investor Conference Features Business Strategy Updates and New Technologies 6Hill-Rom Investor Conference Features Business Strategy Updates and New Technologies 7Rib-X Pharmaceuticals Enters into Collaborative Agreement on Delafloxacin with Massachusetts General Hospital 2Rib-X Pharmaceuticals Enters into Collaborative Agreement on Delafloxacin with Massachusetts General Hospital 3Exenatide Once Weekly Provided Superior Glucose Control Compared to BYETTA(R) in DURATION-5 Study 2Exenatide Once Weekly Provided Superior Glucose Control Compared to BYETTA(R) in DURATION-5 Study 3Exenatide Once Weekly Provided Superior Glucose Control Compared to BYETTA(R) in DURATION-5 Study 4Exenatide Once Weekly Provided Superior Glucose Control Compared to BYETTA(R) in DURATION-5 Study 5Exenatide Once Weekly Provided Superior Glucose Control Compared to BYETTA(R) in DURATION-5 Study 6Exenatide Once Weekly Provided Superior Glucose Control Compared to BYETTA(R) in DURATION-5 Study 7First Defense Nasal Screen Comp Releases New Protection Product Just in Time for Pandemic Flu Season 55643 1First Defense Nasal Screen Comp Releases New Protection Product Just in Time for Pandemic Flu Season 55643 2First Defense Nasal Screen Comp Releases New Protection Product Just in Time for Pandemic Flu Season 55643 3First Defense Nasal Screen Comp Releases New Protection Product Just in Time for Pandemic Flu Season 55643 4Waismann Method Offers Safe Treatment for Dependency to Benzodiazepines 55641 1Waismann Method Offers Safe Treatment for Dependency to Benzodiazepines 55641 2Waismann Method Offers Safe Treatment for Dependency to Benzodiazepines 55641 3Watson Pharmaceuticals Receives FDA Approval for Generic PLAN B 28R 29 for Over the Counter Use 55640 1Watson Pharmaceuticals Receives FDA Approval for Generic PLAN B 28R 29 for Over the Counter Use 55640 2
... /PRNewswire/ -- At the April AACR,Annual Meeting, Indivumed ... a new drug test-platform to predict drug,response in ... currently the first,choice for cancer drug testing. During ... protein expression patterns,change significantly, thereby losing many of ...
... 2007 - Insmed Inc.,(Nasdaq:INSM) today announced positive results ... drug, IPLEX(TM), in,patients with myotonic muscular dystrophy (DM1)., ... at,the University of Rochester School of Medicine and ... of IPLEX up to 1,mg/kg/day in six patients ...
Other Medicine Technology:Indivumed Study Provides Sound Scientific Basis for a Predictive,Drug Test- Platform 2Insmed Announces Promising Results From IPLEX Phase II Myotonic,Muscular Dystrophy Clinical Study 2Insmed Announces Promising Results From IPLEX Phase II Myotonic,Muscular Dystrophy Clinical Study 3Insmed Announces Promising Results From IPLEX Phase II Myotonic,Muscular Dystrophy Clinical Study 4
Polyester ribbon impregnated with conjugated Protein A - .25 OD per sq. cm....
Polyester ribbon impregnated with conjugated Protein G - .25 OD per sq. cm....
Colloidal Gold Sol, 40 nm - 12 - 15, 1 ml, Gold Sol Nanoparticles - not boiled, not centrifuged...
Onyx Liquid Embolic System is a device utilized for the pre-surgical embolization of arteriovenous malformations (AVMs)....
Medicine Products: